Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction

Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications

(2009) Jianli Niu et al.   CLINICAL SCIENCE

HMG-CoA Reductase Inhibitor Improves Endothelial Dysfunction in Spontaneous Hypertensive Rats Via Down-regulation of Caveolin-1 and Activation of Endothelial Nitric Oxide Synthase

(2009) Jung-Won Suh et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease

(2009) Emma Robinson et al.   PHARMACOLOGY & THERAPEUTICS

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

(2008) Kenneth Dickstein et al.   EUROPEAN JOURNAL OF HEART FAILURE

Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats

(2008) Pierre Sicard et al.   FREE RADICAL RESEARCH

Experimental and Clinical Basis for the Use of Statins in Patients With Ischemic and Nonischemic Cardiomyopathy

(2008) Kumudha Ramasubbu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

Observational Studies of Statins in Heart Failure with Preserved Systolic Function

(2008) Hidekatsu Fukuta et al.   Heart Failure Clinics